BR112021006250A2 - método, e, método para rompimento seletivo de uma ou mais camadas de gordura subcutânea - Google Patents

método, e, método para rompimento seletivo de uma ou mais camadas de gordura subcutânea

Info

Publication number
BR112021006250A2
BR112021006250A2 BR112021006250A BR112021006250A BR112021006250A2 BR 112021006250 A2 BR112021006250 A2 BR 112021006250A2 BR 112021006250 A BR112021006250 A BR 112021006250A BR 112021006250 A BR112021006250 A BR 112021006250A BR 112021006250 A2 BR112021006250 A2 BR 112021006250A2
Authority
BR
Brazil
Prior art keywords
subcutaneous fat
fat layer
superficial
deep
layers
Prior art date
Application number
BR112021006250A
Other languages
English (en)
Inventor
Velis Christopher
JAVORSKY Emilia
Miller Karen
Gupta Rainuka
S Chaudhry Tarik
Original Assignee
Miraki Innovation Think Tank Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miraki Innovation Think Tank Llc filed Critical Miraki Innovation Think Tank Llc
Publication of BR112021006250A2 publication Critical patent/BR112021006250A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A61B18/0218—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques with open-end cryogenic probe, e.g. for spraying fluid directly on tissue or via a tissue-contacting porous tip
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/12—Devices for heating or cooling internal body cavities
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00041—Heating, e.g. defrosting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452—Skin
    • A61B2018/00458—Deeper parts of the skin, e.g. treatment of vascular disorders or port wine stains
    • A61B2018/00464—Subcutaneous fat, e.g. liposuction, lipolysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A61B2018/0293—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques using an instrument interstitially inserted into the body, e.g. needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling
    • A61F2007/0282—Compresses or poultices for effecting heating or cooling for particular medical treatments or effects
    • A61F2007/029—Fat cell removal or destruction by non-ablative heat treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/12—Devices for heating or cooling internal body cavities
    • A61F2007/126—Devices for heating or cooling internal body cavities for invasive application, e.g. for introducing into blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Thermal Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

método, e, método para rompimento seletivo de uma oumais camadas de gordura subcutânea. uma pasta fluida é injetada em um indivíduo em um sítio de tratamento selecionado do grupo que consiste em (i) uma camada de gordura subcutânea profunda, (ii) uma camada de gordura subcutânea superficial, e (iii) a camada de gordura subcutânea profunda e a camada de gordura subcutânea superficial. células de gordura no sítio de tratamento selecionado são ablacionadas pela pasta fluida. por exemplo, a pasta fluida é injetada (i) apenas na camada de gordura subcutânea profunda, (ii) apenas na camada de gordura subcutânea superficial, (iii) na camada de gordura subcutânea profunda seguida pela camada de gordura subcutânea superficial, (iv) na camada de gordura subcutânea superficial seguida pela camada de gordura subcutânea profunda, ou (v) na camada de gordura subcutânea profunda e a camada de gordura subcutânea superficial simultaneamente.
BR112021006250A 2018-10-04 2019-10-04 método, e, método para rompimento seletivo de uma ou mais camadas de gordura subcutânea BR112021006250A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862741286P 2018-10-04 2018-10-04
PCT/US2019/054834 WO2020072983A1 (en) 2018-10-04 2019-10-04 Methods of treating subcutaneous fat layers

Publications (1)

Publication Number Publication Date
BR112021006250A2 true BR112021006250A2 (pt) 2021-07-06

Family

ID=70054988

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021006250A BR112021006250A2 (pt) 2018-10-04 2019-10-04 método, e, método para rompimento seletivo de uma ou mais camadas de gordura subcutânea

Country Status (13)

Country Link
US (1) US20220008110A1 (pt)
EP (1) EP3860548A4 (pt)
JP (1) JP2022508645A (pt)
KR (1) KR20210073541A (pt)
CN (1) CN113164321A (pt)
AU (1) AU2019355657A1 (pt)
BR (1) BR112021006250A2 (pt)
CA (1) CA3115260A1 (pt)
IL (1) IL281877A (pt)
MX (1) MX2021003825A (pt)
SG (1) SG11202103368XA (pt)
TW (1) TW202025996A (pt)
WO (1) WO2020072983A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016033380A1 (en) 2014-08-28 2016-03-03 The General Hospital Corporation Compositions and methods for treatment of neurological disorders
WO2022032111A1 (en) * 2020-08-07 2022-02-10 Miraki Innovation Think Tank Llc Iced-water slurry for treating brown and beige fat

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019988A (en) * 1996-11-18 2000-02-01 Bristol-Myers Squibb Company Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage
US20080045880A1 (en) * 2006-02-11 2008-02-21 Rune Kjeken Device and method for single-needle in vivo electroporation
US7740612B2 (en) * 2007-07-27 2010-06-22 Milestone Scientific, Inc Self-administration injection system
US8535275B2 (en) * 2008-06-26 2013-09-17 Bellanovus Development Company Llc Syringe-attached topical anesthetic dispenser
US9458505B2 (en) * 2011-12-20 2016-10-04 The Cleveland Clinic Foundation Diagnosis of cowden and cowden-like syndrome by detection of decreased killin expression
KR101563287B1 (ko) * 2013-10-23 2015-10-27 주식회사 하이로닉 지방 분해 장치
WO2016033380A1 (en) * 2014-08-28 2016-03-03 The General Hospital Corporation Compositions and methods for treatment of neurological disorders
US20160081974A1 (en) * 2014-09-18 2016-03-24 Research & Business Foundation Sungkyunkwan University Composition for preventing or treating edema containing flavonoid compound
CN205494702U (zh) * 2016-03-24 2016-08-24 上海新肌生物科技有限公司 一种可达筋膜层smas的微型超声刀溶脂仪
US11324673B2 (en) * 2016-11-18 2022-05-10 Miraki Innovation Think Tank Llc Cosmetic appearance of skin

Also Published As

Publication number Publication date
AU2019355657A1 (en) 2021-05-13
WO2020072983A1 (en) 2020-04-09
KR20210073541A (ko) 2021-06-18
US20220008110A1 (en) 2022-01-13
MX2021003825A (es) 2021-09-08
CN113164321A (zh) 2021-07-23
IL281877A (en) 2021-05-31
SG11202103368XA (en) 2021-04-29
AU2019355657A8 (en) 2021-06-03
CA3115260A1 (en) 2020-04-09
EP3860548A4 (en) 2022-06-01
EP3860548A1 (en) 2021-08-11
JP2022508645A (ja) 2022-01-19
TW202025996A (zh) 2020-07-16

Similar Documents

Publication Publication Date Title
BR112017019738A2 (pt) macrociclos peptidomiméticos e usos dos mesmos
BR112017020973A2 (pt) método para tratar câncer em um paciente
BR112017005598A2 (pt) macrociclos peptidomiméticos e usos dos mesmos
PE20180260A1 (es) Metodos y kits para tratar la depresion
BR112017006302A2 (pt) composição de circulação perdida, método para obstruir uma zona de circulação perdida e sistema para obstruir uma zona de circulação perdida
BR112017025813A2 (pt) método, kit ou composição, micróbio comensal benéfico, método para tratar ou prevenir o câncer e formulação bacteriana
BR112017026709A2 (pt) tratamento e diagnóstico de câncer
MX2021010528A (es) Metodos y composiciones para el tratamiento de las ulceras.
MX2020003959A (es) Metodos terapeuticos relacionados con los inhibidores de hsp90.
BR112017007767A2 (pt) canabidiol para uso, método para tratar um paciente que sofre de complexo esclerose tuberosa, e, composição.
BR112015023203A8 (pt) métodos para tratamento de câncer, método para aumentar a eficiência de um tratamento de câncer, método para retardar e/ou prevenir o desenvolvimento de câncer, método para tratar um indivíduo com câncer, método para aumentar a sensibilidade para um agente de terapia para câncer, método para estender um período de sensibilidade e método para estender a duração da resposta para uma terapia para câncer.
BR112017006113A2 (pt) combinações sinérgicas de auristatina
CL2021002669A1 (es) (divisional de solicitud 3443-2018) tratamientos de cancer.
BR112015017767A2 (pt) sistema para detectar estágios do sono de um indivíduo, método para detectar estágios do sono de um indivíduo, e, sistema configurado para detectar estágios do sono de um indivíduo
MX2018002344A (es) Metodo para tratar el cancer.
BR112021006250A2 (pt) método, e, método para rompimento seletivo de uma ou mais camadas de gordura subcutânea
BR112018071600A2 (pt) métodos, composições e usos relacionados aos mesmos
WO2019090347A8 (en) Adenosine pathway inhibitors for cancer treatment
BR112017007498A2 (pt) método de tratamento de uma porção de um poço, sistema de poço, e, fluido de tratamento de poço.
BR112022004067A2 (pt) Método e sistema para o tratamento de celulite
BR112017011642A2 (pt) composto, sal farmaceuticamente aceitável, e, método para tratamento de uma doença ou condição que se beneficia de um aumento em nad+.
BR112017027277A2 (pt) ?método para o tratamento ou prevenção de uma doença e métodos para matar uma célula?
BR112018011362A2 (pt) método para tratar uma formação subterrânea e fluido de tratamento
BR112016029635A2 (pt) derivados pirazolo-piridina como inibidores de quinase
CL2018003167A1 (es) Selección de cepas bacterianas útiles en el tratamiento de alergias.

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements